microdosing semaglutide vs tirzepatide Macrodosing GLP-1: The Risks of Taking Too Much — INTRA|V Semaglutide vs Tirzepatide for Weight

People who should not take lipotropic injections include those who are pregnant or breastfeeding, individuals with a known allergy to any of the injection ingredients (particularly sulfa-related sensitivities due to methionine), people with severe liver or kidney disease, and those taking certain medications that may interact with the supplement ingredients

According to the Joi + Blokes GLP-1 page, the most common side effects reported with semaglutide and tirzepatide include nausea, vomiting, diarrhea, constipation, bloating or gas, decreased appetite, and fatigue

No significant adverse effects were reported at doses up to 1mg per day over 24 weeks

Although there is a lack of direct studies on semaglutide, the observed actions align with those of other GLP-1R agonists, indicating a potential impact on cancer

Traditional blood pressure medications are designed specifically to lower blood pressure through mechanisms that affect blood vessels, fluid balance, or heart function

These include nausea, vomiting, diarrhoea, constipation, abdominal discomfort, and reduced appetite, as documented in the UK SmPC